Genetic architecture of lumbar spinal stenosis

Ville Salo,Juhani Maatta,Jasmin Takala,Anni Heikkila,FinnGen,Ene Reimann,Reedik Magi,Estonian Biobank research team,Kadri Reis,Abdelrahman G Elhanas,Anu Reigo,Priit Palta,Tonu Esko,Ville Leinonen,Jaro Karppinen,Eeva Sliz,Johannes Kettunen

DOI: https://doi.org/10.1101/2024.10.16.24315641

2024-10-18

Abstract:Over 100 million people worldwide suffer from lumbar spinal stenosis (LSS) with increasing incidence with ageing population, yet little is known about the LSS genetic background. Given the high cost of treating LSS, a deeper understanding of LSS pathogenesis may eventually result in the development of novel preventative and treatment methods, potentially leading to reductions in related societal costs. Our aim is to gain a better understanding of the genetic components underlying LSS. In the FinnGen, Estonian, and UK biobanks, we conduct a genome-wide association study (GWAS) of LSS and merge the results in the genome-wide meta-analysis. In addition to the seven known risk loci, our meta-analysis reveals 47 loci that have not been associated with LSS in previous studies. Many downstream analyses and multiple candidate genes discovered from the LSS-associated loci suggest that spinal degeneration plays a major role in the pathogenesis of LSS.

What problem does this paper attempt to address?

### The Problem the Paper Aims to Address

This paper aims to gain an in-depth understanding of the genetic background of Lumbar Spinal Stenosis (LSS). Although LSS affects over 100 million people worldwide and its incidence continues to increase with an aging population, its genetic mechanisms remain poorly understood. Understanding the genetic components of LSS not only helps to reveal its pathogenesis but may also provide clues for developing new prevention and treatment methods, thereby reducing related social costs.

Specifically, the research team conducted genome-wide association studies (GWAS) in FinnGen, the Estonian Biobank, and the UK Biobank, and performed a genome-wide meta-analysis to identify genetic loci associated with LSS. The main objectives of the study include:

1. **Discover new genetic loci**: Identify previously unreported genetic loci associated with LSS.
2. **Validate known loci**: Validate known LSS risk loci from previous studies.
3. **Analyze gene function**: Investigate the candidate genes within these genetic loci and their potential roles in the pathogenesis of LSS.
4. **Evaluate surgical cases**: Conduct sensitivity analysis on LSS patients requiring surgical treatment to identify specific genetic variations.
5. **Explore genetic correlations**: Analyze the genetic correlations between LSS and other diseases or traits.
6. **Age-related analysis**: Study the relationship between the age of onset of LSS and genetic variations.

Through these analyses, the research team hopes to provide a more comprehensive understanding of the genetic basis of LSS, offering scientific evidence for future prevention and treatment strategies.